Spain fines pharmaceuticals cartel €5.8 million
Credit: Shutterstock/kofana12
Spain's antitrust enforcer has fined the country's only two suppliers of drugs used in nuclear medicine – including a local Novartis subsidiary – for dividing the market and rigging tenders.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10